Drug Discovery & Trials

Targets, biomarkers, AI discovery, and Phases I–III clinical results.

  • 19 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Drug Discovery & Trials


politico.eu > article > novo-turns-to-anthropic-to-turbocharge-medical-research

Ozempic-maker turns to Anthropic to turbocharge medical research

1+ hour, 4+ min ago   (293+ words) The Danish pharma giant Novo said AI tools offer “completely new scientific opportunities.” Novo and Anthropic announced today a collaboration to accelerate the development of new medicines and AI-driven software. The news landed hours after European Commission President Ursula von…...


wsau.com > 09/16/2026 > novo-partners-with-anthropic-to-speed-up-drug-development-with-claude

Novo partners with Anthropic to speed up drug development with Claude

1+ hour, 48+ min ago   (202+ words) Sept 16 (Reuters) – Novo Nordisk has partnered with Anthropic to use the AI giant’s Claude models to speed up ​discovery and development of new ‌medicines, the companies said on Wednesday. • The Danish drugmaker will initially test Anthropic models and Claude Science…...


news-medical.net-medical.net

ACROBiosystems deepens its France presence with a dedicated hub at The HIVE Innovation Center, embedding into the Campus Grand Parc ecosystem

4+ hour, 31+ min ago   (191+ words) Kadans Science Partner is pleased to welcome ACROBiosystems to The HIVE Innovation Center, its laboratory and office building dedicated to the life sciences, situated on the Campus Grand Parc in Villejuif. ACROBiosystems’ arrival at The HIVE takes the form of…...


distilledpost.com > post > durham-spinout-magnitude-biosciences-raises-ps1-3m-to-expand-drug-discovery-platform

Durham Spinout Magnitude Biosciences Raises £1.3m to Expand Drug Discovery Platform

4+ hour, 32+ min ago   (357+ words) Magnitude Biosciences, a life sciences company spun out of Durham University, has raised £1.3 million to scale its drug discovery platform and expand its work with pharmaceutical companies. The company has developed VivoScan, a high throughput screening platform that uses C....


clinicaltrialvanguard.com > executiveinterviews > when-the-trial-ends-the-data-work-begins

When the Trial Ends, the Data Work Begins

4+ hour, 51+ min ago   (384+ words) Moe: Why did IAG validate the Ferring proof-of-concept against real-world clinical data rather than expanding the trial dataset? The trial was already finished, the data already collected, so expanding that database was not possible. But it was a great dataset…...


newswire.com > news > iq-biosciences-and-bioz-celebrate-a-longstanding-partnership-advancing-cellular

iQ Biosciences and Bioz Celebrate a Longstanding Partnership Advancing Cellular Product Discovery

7+ hour, 4+ min ago   (294+ words) For several years, iQ Biosciences has leveraged Bioz Badges across its cellular product webpages to give researchers immediate access to peer-reviewed scientific evidence supporting its products. The partnership helps scientists understand how iQ Biosciences products have been used in published…...


issuewire.com > end-to-end-drug-development-how-an-integrated-crdmo-connects-discovery-cmc-and-manufacturing-1876389248265955

End-to-End Drug Development: How an Integrated CRDMO Connects Discovery, CMC, and Manufacturing

9+ hour ago   (1098+ words) End to End Drug Development San Diego, California Sep 15, 2026 (Issuewire.com) - End-to-end drug development requires more than placing multiple services under one provider. A genuinely integrated model connects scientific work, CMC development, quality systems, and manufacturing so that decisions, materials,…...


hilltimes.com > 09/16/2026 > biotechnology-the-brain-gain-arrives-at-an-empty-treasury > 517597

Biotechnology: the brain gain arrives at an empty treasury

10+ hour ago   (38+ words) The Hill Times Biotechnology: the brain gain arrives at an empty treasury To keep reading, subscribe and become a political insider. Only $7.76 a week for an annual subscription....